2024.10.15 提交
2024.10.19 拒绝

Submitted on 2024.10.15
Rejected on 2024.10.19

(0) 讚！ | mlllll

May I ask, has the eye artificial intelligence article you submitted been requested to provide "clinical trial registration information"? Looking forward to your reply, thank you very much.

(0) 讚！ | prosmail

May I ask if the author has been asked to provide "clinical trial registration information" when publishing papers? Looking forward to your reply, thank you very much.

(0) 讚！ | prosmail

This journal has a quick review process, with results typically available within 7 days of submission. Unfortunately, our submission on machine learning and osteoporosis was rejected.

(1) 讚！ | 黄桂雄

How did the results turn out?

(0) 讚！ | 因小林

Those two e-starting ones, such as ebiomedicine. If it's my direction, Healthy Longevity is also okay

(0) 讚！ | alex_zhao_zi

Excuse me, have you found the answer? Are co-first authors allowed? (I checked the journal requirements, and it allows for co-corresponding authors, but there is no mention of co-first authors

(0) 讚！ | SCIM

May I ask, what are the two Lancet open-source journals that you mentioned?

(0) 讚！ | SCIM

The review process was fast and there weren't many difficult comments, but the journal's word count requirement was too low. Even after two rounds of reducing the word count, it was still challenging. In the future, journals at a similar level should consider the two open access journals below The Lancet

(0) 讚！ | alex_zhao_zi

How long is the submission cycle?

(0) 讚！ | Sid_

Finding reviewers was difficult, it took a long time but still didn't have all 3 reviewers in place. By the deadline, the editor had received a lot of feedback from the reviewers. Each reviewer was very professional, pointing out sharp and detailed questions. The revision time was short, but the acceptance came quickly after the revisions

(0) 讚！ | letpubyan

Second time’s a charm, give me some hope

(1) 讚！ | evayfang

What happened later?

(0) 讚！ | undefined

This journal cannot be seen in the status of submission. After submitting, it quickly goes under review, and I don't know the progress.

(0) 讚！ | letpubyan

Is it allowed to have co-authors?

(0) 讚！ | 盛依米

The person upstairs belongs to the group of colleagues led by Wei Wenbin.

(0) 讚！ | 哥天牛

The article on ophthalmic artificial intelligence is overall very innovative, but technically it is a refinement of previous work. It was submitted to Nature, Science, Ophthalmology, and JAMA Ophthalmology, but it didn't even get a chance to be reviewed. On October 31, 2020, it was resubmitted to this journal, and on January 21, 2021, we received a letter from the editor. Based on the tone, we inferred that they were already 90% inclined to accept it and requested a response within three weeks. The three reviewers they invited are well-known experts in the industry who highly appreciate our research but also raised professional questions. After we replied on time, we received the confirmation of acceptance and DOI number on March 18. We made three revisions and it was published on May 5. The entire communication process was professional and fast. Of course, the prerequisite was that the content of the article had to be good.

(5) 讚！ | sallyjoya

After the first review, I received an acceptance letter in about half a month. I am very happy and hope that all my friends can give this journal a try. The quality of the articles is good, and the future looks promising!

(0) 讚！ | kuku1116

The content is quite clever, so the editorial department generally considers it for publication after some minor revisions. However, the opinions of the third reviewer are still somewhat complex, mainly involving several modifications to the description of the statistical plan. The quality of the paper is high, as the real-time Impact Factor (IF) is already close to 10. As mentioned above, it is expected to reach 11-12 this year. Interested children can give it a try. It is an open-access journal, with slightly lower requirements compared to professional journals.

(4) 讚！ | kuku1116

The level of the magazines published by JNO is getting higher and higher now, and it feels like the impact factor will be similar to JAMA Surgery! In the future, it is expected to maintain around 12-13 points.

(19) 讚！ | 大阳